Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Price up, volume up, earnings to follow

Cedar Woods Properties
3:27pm
February 24, 2024
This reporting season has seen improved commentary around the residential housing sector and a nascent housing recovery. CWP report the highest enquiry and sales levels in two years for 2Q24, with price increases across its key markets, most notably WA where prices were up 5% to 13% in 1H24. CWP is a volume business and the demand for lots looks to be improving, with margins to invariably follow. CWP’s exposure to lower priced stock in higher growth markets sees further potential to drive earnings. On this basis, we see every reason for CWP to trade at NTA and potentially at a premium, were the housing cycle to gain steam through FY25/26. On this basis, we upgrade CWP to an ADD, with a price target of $5.60/sh.

Still a long way to go

Experience Co
3:27pm
February 24, 2024
EXP’s 1H24 result was in line with our forecasts. The 2H24 looks to have had a decent start with January trading in line with the pcp despite all the wet weather and EXP has also seen positive trading into February. EXP will likely be the last of our travel companies under coverage to fully recover from COVID given its leverage to inbound international tourists to Australia (in particular the Chinese) which continues to lag the wider travel recovery. However, material upside remains on offer for the patient investor. ADD maintained.

Tailwinds still roaring

Fortescue
3:27pm
February 23, 2024
A bumper 1H24 earnings and dividend result from FMG. 5% EBITDA beat and in-line underlying NPAT vs consensus. Interim dividend of AUD 108 cents, also above expectations. FY24 production and cost guidance maintained. FMG now trading at a premium to BHP/RIO is indicative of a solid share price performance, but not a good endorsement of value. We maintain a Hold rating.

Strong pricing but underlying conditions remain soft

Brambles
3:27pm
February 23, 2024
BXB’s 1H24 result was above expectations. Key positives: Group EBIT margin rose 160bp to 20.3% driven by growth in CHEP Americas and CHEP EMEA; ROIC increased 200bp to 21.8%; FY24 guidance for earnings and free cash flow was upgraded. Key negatives: CHEP Asia-Pacific EBIT margin fell 240bp to 34.4%; Group like-for-like (LFL) volumes fell 1%, impacted by customer destocking; Management said the contract environment has become more competitive. We increase FY24-26F underlying EBIT by 2%. Our target price rises to $15.65 (from $14.95) and we maintain our Hold rating.

Mid-year could potentially provide the key catalyst

PEXA Group
3:27pm
February 23, 2024
PXA’s 1H24 Group NPATA (A$15m) was down -36% on the pcp, and slightly below consensus (A$17m). This result had been heavily pre-announced and headline figures were largely as expected with FY24 guidance re-affirmed (albeit PXA Exchange margins are tracking slightly above the top end of the range). The key stock catalyst here remains the launch of the 24- hour UK refinance product in the middle of 2024, which management says remains on track. We make nominal changes to our PXA FY24F/FY25F EBITDA forecasts (+1%-2%) but our NPATA forecasts fall by -22%/-4% on higher non-operating items, e.g. specified items and D&A, etc. Our valuation rises to A$12.19 on higher future operating earnings and a valuation roll-forward. HOLD maintained.

1H24 earnings: Lace up

Accent Group
3:27pm
February 23, 2024
EBIT was 4% lower than forecast and down 11% on a pro forma basis. AX1 said it does not believe consumer demand has changed “fundamentally”, but there is a “little bit of softness” at present. AX1 has performed best where its brands are “hot” (such as HOKA). Against elevated comps, LFLs were resilient at (0.6)% in the first half and have started 2H24 at a similar pace. The comps get less demanding as the half goes on and we expect positive LFLs in 2H24 as a whole. This resilience is a function of the portfolio effect and strong market position. We have lowered our EBIT estimates by 2% in FY24 and FY25 due to higher D&A and retain an Add rating and $2.30 target price.

1H mixed- the end of “market dislocation”?

Ansell
3:27pm
February 23, 2024
1H was mixed, with an inline double-digit earnings decline, but on softer revenue and underlying profit. OPM expanded in Industrial on manufacturing efficiencies and carryover pricing, but was more than offset by contracting margins in Healthcare on continued inventory destocking and slowing of production to address inflated inventories. While a 2H recovery appears reasonable, as a proportion of earnings is driven by cost-outs/efficiencies, we remain cautious on the end of this multi-year “market dislocation” especially as gains are reliant on exogenous factors (eg supportive macros and limited customer destocking), while APIP unfolds over time. While FY24-26 estimates move lower, we roll forward valuation multiples with our DCF/SOTP PT increasing to A$22.53. Hold.

Improved cost control sees margin expansion

Wagners
3:27pm
February 23, 2024
Whilst the result was largely pre-released, the underlying 1HFY24 EBIT of $20.0m reflects a significant improvement on the $4.4m achieved in the pcp. The construction materials division was the primary driver, where EBIT increased 95% on the pcp as improved prices, volumes and cost control saw EBIT margins increase to 11.8% (1H23: 7.4%). The result really points to the cyclical nature of the industry and WGN’s leverage to an improving cycle. The positive operating environment, combined with continued M&A across the industry (ABC, BLD, CSR all receiving bids) all bode well for WGN. On this basis we have changed our recommendation to an ADD rating (previously Speculative Buy) reflecting lower earnings and valuation risk, whilst leaving our target price unchanged at $1.15/sh.

Not as clean as hoped

Medibank
3:27pm
February 22, 2024
MPL’s 1H24 underlying NPAT (A$263m) was +16% on the pcp, and -1% below company-compiled consensus (A$266m).  We saw this as a bit of a mixed result overall. Whilst the Health Insurance (HI) claims environment remains favourable, revised FY24 HI policyholder guidance and management expense growth guidance both disappointed. We make relatively nominal changes to our MPL FY24F/FY25F EPS of -1%/+2% reflecting lower claims forecasts, reduced policyholder growth expectations and higher HI operating expenses. Our PT is set at A$3.73 (previously A$3.76). The current operating environment still appears relatively favourable for MPL, but we see the stock as fair value trading on ~19x FY24F PE. HOLD maintained

No news is good news

Pilbara Minerals
3:27pm
February 22, 2024
PLS reported a soft 1H24 earnings result against consensus expectations, but given there was no significant news and the stock is highly shorted, the miss did not move the stock price greatly. 1H24 underlying EBITDA of A$415m was -8% vs Visible Alpha consensus, while underlying NPAT of A$273m was -15% vs consensus. P680 and P1000 projects are on schedule and budget. FY24 capex guidance reduce to manages costs. Maintain our Add rating with a $4.50ps Target Price. Besides the miss a quiet result for PLS. We expect the stock to re-rate in a broader lithium recovery.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more